Literature DB >> 22315243

Diagnosis and management of Raynaud's phenomenon.

Beth Goundry1, Laura Bell, Matthew Langtree, Arumugam Moorthy.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 22315243     DOI: 10.1136/bmj.e289

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  16 in total

1.  Raynaud's phenomenon in Northern Sweden: a population-based nested case-control study.

Authors:  Albin Stjernbrandt; Hans Pettersson; Ingrid Liljelind; Tohr Nilsson; Jens Wahlström
Journal:  Rheumatol Int       Date:  2018-08-20       Impact factor: 2.631

2.  A Randomized Controlled Trial of Acupressure for the Treatment of Raynaud's Phenomenon: The difficulty of conducting a trial in Raynaud's phenomenon.

Authors:  Heather Gladue; Veronica Berrocal; Richard Harris; Pei-Suen Tsou; Gautam Edhayan; Ray Ohara; Dinesh Khanna
Journal:  J Scleroderma Relat Disord       Date:  2016-05-02

3.  Conversion to Paradoxical Finding on Technetium-99m-labeled RBC Scintigraphy after Treatment for Secondary Raynaud's Phenomenon.

Authors:  Ari Chong; Jung-Min Ha; Ho-Chun Song; Jahae Kim; Soo Jin Na Choi
Journal:  Nucl Med Mol Imaging       Date:  2013-08-21

Review 4.  Impact of hallmark autoantibody reactivity on early diagnosis in scleroderma.

Authors:  Pia Moinzadeh; Svetlana I Nihtyanova; Kevin Howell; Voon H Ong; Christopher P Denton
Journal:  Clin Rev Allergy Immunol       Date:  2012-12       Impact factor: 8.667

5.  Efficacy of cilostazol for the treatment of Raynaud's phenomenon in systemic sclerosis patients.

Authors:  Simone Negrini; Francesca Spanò; Elena Penza; Daniela Rollando; Francesco Indiveri; Gilberto Filaci; Francesco Puppo
Journal:  Clin Exp Med       Date:  2015-06-19       Impact factor: 3.984

6.  Treatment of Raynaud's phenomenon with botulinum toxin type A.

Authors:  Xiaolong Zhang; Yong Hu; Zhiyu Nie; Ye Song; Yougui Pan; Ying Liu; Lingjing Jin
Journal:  Neurol Sci       Date:  2015-01-24       Impact factor: 3.307

Review 7.  International consensus criteria for the diagnosis of Raynaud's phenomenon.

Authors:  Emanual Maverakis; Forum Patel; Daniel G Kronenberg; Lorinda Chung; David Fiorentino; Yannick Allanore; Serena Guiducci; Roger Hesselstrand; Laura K Hummers; Chris Duong; Bashar Kahaleh; Alexander Macgregor; Marco Matucci-Cerinic; Frank A Wollheim; Maureen D Mayes; M Eric Gershwin
Journal:  J Autoimmun       Date:  2014-02-01       Impact factor: 7.094

8.  Raynaud phenomenon and mortality: 20+ years of follow-up of the Charleston Heart Study cohort.

Authors:  Paul J Nietert; Stephanie R Shaftman; Richard M Silver; Bethany J Wolf; Brent M Egan; Kelly J Hunt; Edwin A Smith
Journal:  Clin Epidemiol       Date:  2015-02-03       Impact factor: 4.790

9.  Cutaneous manifestations of systemic lupus erythematosus.

Authors:  Luís Uva; Diana Miguel; Catarina Pinheiro; João Pedro Freitas; Manuel Marques Gomes; Paulo Filipe
Journal:  Autoimmune Dis       Date:  2012-07-25

10.  Monostotic fibrous dysplasia with Raynaud's phenomenon.

Authors:  K V S Hari Kumar; K Aravinda; K Narayanan
Journal:  J Nat Sci Biol Med       Date:  2015 Jul-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.